01/24/2008
TVM Capital Promotes Dr. Keiarasch ‘Kia’ Parssanedjad to Principal
January 24, 2008, Munich, Germany - Dr. Kia Parssanedjad joined the TVM Capital life sciences practice in early 2007 as a senior associate, based in Munich. As a principal, he will be involved in deal origination and the evaluation of new investments, as well as research and support for existing portfolio companies with an emphasis on clinical development stage to commercial stage investments.
“As a member of the deal team on our recent growth capital investment into Riemser Arzneimittel AG he has shown that he is a great addition to our professional team ,” said Dr. Helmut M. Schühsler, managing partner for TVM Capital. “He brings to TVM Capital strategic consulting as well as startup capabilities. His past experience in buyout and growth transactions, strategy development, marketing and sales in our core target market, the pharmaceutical industry, nicely complements our operational expertise and deep scientific and commercial understanding.”
Dr. Parssanedjad completed medical studies at the University of Essen, Germany, at Harvard University, Boston, USA and at St. Johns Medical College, Bangalore, India and holds a doctor degree for his molecular biological work in the field of gene therapy. Prior to joining TVM Capital, he worked as an Engagement Manager for McKinsey & Company, where he served pharmaceutical and private equity clients.
Press Contact
Monika Schlesinger
TVM Capital GmbH
Maximilianstr. 35, Eingang C
D- 80539 Munich, Germany
++49 (89) 998 992-0
Nancy Saucier
TVM Capital
101 Arch Street, Suite 1950
Boston, MA 02110, USA
+1 (617) 345 9320
